Literature DB >> 17507496

Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception.

Ida Marabese1, Francesca Rossi, Enza Palazzo, Vito de Novellis, Katarzyna Starowicz, Luigia Cristino, Daniela Vita, Luisa Gatta, Francesca Guida, Vincenzo Di Marzo, Francesco Rossi, Sabatino Maione.   

Abstract

The current study has investigated the involvement of periaqueductal gray (PAG) metabotropic glutamate subtype 7 and 8 receptors (mGluR(7) and mGluR(8)) in modulating rostral ventromedial medulla (RVM) ongoing and tail flick-related on and off cell activities. Our study has also investigated the role of PAG mGluR(7) on thermoceptive threshold and PAG glutamate and GABA release. Intra-ventrolateral PAG (S)-3,4-dicarboxyphenylglycine [(S)-3,4-DCPG (2 and 4 nmol/rat)] or N,N(I)-dibenzhydrylethane-1,2-diamin dihydrochloride (AMN082, (1 and 2 nmol/rat), selective mGluR(8) and mGluR(7) agonists, respectively, caused opposite effects on the ongoing RVM on and off cell activities. Tail flick latency was increased or decreased by (S)-3,4-DCPG or AMN082 (2 nmol/rat), respectively. (S)-3,4-DCPG reduced the pause and delayed the onset of the off cell pause. Conversely, AMN082 increased the pause and shortened the onset of off cell pause. (S)-3,4-DCPG or AMN082 did not change the tail flick-induced onset of on-cell peak firing. The tail flick latency and its related electrophysiological effects induced by (S)-3,4-DCPG or AMN082 were prevented by (RS)-alpha-methylserine-o-phosphate (100 nmol/rat), a group III mGluR antagonist. Intra-ventrolateral PAG perfusion with AMN082 (10 and 25 microM), decreased thermoceptive thresholds and glutamate extracellular levels. A decrease in GABA release was also observed. These results show that stimulation of PAG mGluR(8) or mGluR(7) could either relieve or worsen pain perception. The opposite effects on pain behavior correlate with the opposite roles played by mGluR(7) and mGluR(8) on glutamate and GABA release and the ongoing and tail flick-related activities of the RVM on and off cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507496     DOI: 10.1152/jn.00356.2007

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  22 in total

1.  Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

Authors:  D R Cleary; M J Neubert; M M Heinricher
Journal:  Neuroscience       Date:  2007-11-04       Impact factor: 3.590

2.  Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.

Authors:  Enza Palazzo; Yu Fu; Guangchen Ji; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

Review 3.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

4.  Effects of inducible nitric oxide synthase blockade within the periaqueductal gray on cardiovascular responses during mechanical, heat, and cold nociception.

Authors:  Kevin A Chaitoff; Francis Toner; Anthony Tedesco; Timothy J Maher; Ahmmed Ally
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

5.  Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia?

Authors:  Shivaprakash G; Punya Suvarna; Sanjay Hadigal; Priyanka Kamath; Natesh Prabhu; Ashok Shenoy K; Pallavi Lc
Journal:  J Clin Diagn Res       Date:  2014-09-20

6.  Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.

Authors:  Wenjie Ren; Enza Palazzo; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

Review 7.  Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.

Authors:  Michael C Montana; Robert W Gereau
Journal:  Curr Pharm Biotechnol       Date:  2011-10       Impact factor: 2.837

Review 8.  Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.

Authors:  Xia Li; Zheng-Xiong Xi; Athina Markou
Journal:  Neuropharmacology       Date:  2012-04-21       Impact factor: 5.250

9.  Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain.

Authors:  Enza Palazzo; Ida Marabese; Marie Soukupova; Livio Luongo; Serena Boccella; Catia Giordano; Vito de Novellis; Francesca Rossi; Sabatino Maione
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

10.  The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats.

Authors:  Xia Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2007-11-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.